Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Holders of 5% or more of LEGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Legend Biotech Corp, largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Legend Biotech Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 202511:40 AM ET | FMR LLCand 1 other | 13G/A | 15.00%55.1M shares | +1.10 ppfrom 13.90% | Sep 30, 2025 | SEC |
| Aug 6, 202512:06 PM ET | FMR LLCand 1 other | 13G/A | 13.90%51.0M shares | +3.00 ppfrom 10.90% | Jun 30, 2025 | SEC |
| Jun 6, 202510:03 AM ET | FMR LLCand 1 other | 13G/A | 10.90%40.2M shares | +3.60 ppfrom 7.30% | May 30, 2025 | SEC |
| Feb 14, 20259:44 AM ET | Price T Rowe Associates Inc | 13G/A | 3.70%6.81M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 12, 20259:19 AM ET | FMR LLCand 1 other | 13G/A | 7.30%26.6M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Legend Biotech Corp shares.
No Form 144 notices for Legend Biotech Corp are on file.